Section Arrow
SER.NYSE-M
- Serina Therapeutics
Quotes are at least 15-min delayed:2024/04/28 01:14 EDT
Last
 --
-- (--)
Day High 
-- 
Prev. Close
9.1907 
1-M High
19.93 
Volume 
259 
Bid
5
Ask
12.8
Day Low
-- 
Open
-- 
1-M Low
Market Cap 
22.98M 
Currency USD 
P/E 19.25 
%Yield
10-SMA 10.78 
20-SMA 11.34 
50-SMA 12.99 
52-W High 35.17 
52-W Low
Exchange NYSE-M 
Valuation Estimation
EPS (Current/Estimated)
0.48/--
Enterprise Value
24.66M
Balance Sheet
Book Value Per Share
-14.11
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
34.00K
Operating Revenue Per Share
0.01
Industry Comparison
Code Name   Last Change Change (%) P/E P/E Range
DNAGinkgo Bioworks Holdings0.8601+0.0824+10.60%-- 
BDRXBiodexa Pharmaceuticals plc1.3+0.5752+79.36%-- 
KTRAKintara Therapeutics0.1488-0.0092-5.82%-- 
JAGXJaguar Health0.18+0.01+5.88%-- 
IBRXImmunityBio7.35+2.24+43.84%-- 
Quotes are at least 15-min delayed:2024/04/28 01:14 EDT
Industry overview quotes are at least 15 minutes delayed
Business Description
Serina Therapeutics Inc is a clinical-stage biotechnology company developing a pipeline of wholly-owned drug product candidates to treat neurological diseases and pain. Serina's POZ Platform delivery technology is engineered to provide control in drug loading and more precision in the rate of release of attached drugs, enabling the potential of certain challenging small molecules, while addressing the limitations of polyethylene glycol (PEG) and other biocompatible polymers.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.